These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15286580)

  • 1. [The SOR program of guidelines for clinical practice. Palliative chemotherapy as first line treatment of metastatic colorectal cancer, 2003 update].
    Gastroenterol Clin Biol; 2004 Jun; 28(6-7 Pt 2):E1-71. PubMed ID: 15286580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for clinical practice: management with first-line palliative chemotherapy for patients with metastatic colorectal cancer].
    Conroy T; Adeni A; Bouché O; Merrouche Y; Mitry E; Gory-Delabaere G; ; ; ; ; ; ; ; ; ;
    Bull Cancer; 2006 Feb; 93(2):197-200. PubMed ID: 16521333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
    Conroy T; Gory-Delabaere G; Adenis A; Bosquet L; Bouché O; Louvet C; Mitry E; Bécouarn Y; Bosset JF; Ducreux M; Etienne PL; Merrouche Y; Monges G; Rougier P; ; ; ; ; ; ; ;
    Bull Cancer; 2004 Oct; 91(10):759-68. PubMed ID: 15556876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing therapy for metastatic colorectal cancer.
    Turja J; Grothey A
    Oncology (Williston Park); 2008 Nov; 22(13):1479-81. PubMed ID: 19227569
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal treatment of metastatic colorectal cancer.
    Pessino A; Sobrero A
    Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
    Adams R; Meade A; Wasan H; Griffiths G; Maughan T
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1237-45. PubMed ID: 18699762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for advanced colorectal cancer. Patients need time to reflect on uncertainties surrounding palliative chemotherapy.
    Jeffrey DI
    BMJ; 2001 Jan; 322(7280):234. PubMed ID: 11159629
    [No Abstract]   [Full Text] [Related]  

  • 12. The continuum of care: a paradigm for the management of metastatic colorectal cancer.
    Goldberg RM; Rothenberg ML; Van Cutsem E; Benson AB; Blanke CD; Diasio RB; Grothey A; Lenz HJ; Meropol NJ; Ramanathan RK; Becerra CH; Wickham R; Armstrong D; Viele C
    Oncologist; 2007 Jan; 12(1):38-50. PubMed ID: 17227899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for colorectal cancer.
    Etzioni S; Rosenfeld K
    N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Second-line chemotherapy for colorectal cancer].
    Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
    Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib in metastatic colorectal cancer.
    Grothey A
    Clin Adv Hematol Oncol; 2012 May; 10(5):324-5. PubMed ID: 22706543
    [No Abstract]   [Full Text] [Related]  

  • 19. First-line treatment options for patients with metastatic colorectal cancer.
    Schilsky RL
    Nat Clin Pract Oncol; 2004 Dec; 1(2):70-1. PubMed ID: 16264820
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy for advanced colorectal cancer. Does the evidence or the doctor have the greater influence?
    Munday D
    BMJ; 2001 Jan; 322(7280):233. PubMed ID: 11159627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.